Regulatory Strategies
and Safety
Drug Safety Assessment

TriApex is a study facility that got GLP certification early by NMPA, where the facility operation and study implementation both comply with NMPA, FDA and OECD GLP regulations. We have rich practical experience in nonclinical safety research, and can conduct various nonclinical studies of different products in various animal species according to regulatory requirements or sponsor demands to efficiently support the clinical development and marketing approval.

Service Advantages

1. Compliance

TriApex is a nonclinical study facility that got GLP certification early by NMPA, and is capable of carrying out whole package of non-clinical safety studies of drugs in compliance with NMPA, FDA and OECD GLP regulations.

2. Quality Management System

TriApex has built a high-quality management system with experienced quality assurance (QA) team and comprehensive quality control (QC) process.

3. Project and data management system

By using the efficient project management software, the content and progress of nonclinical research project are visualized. International mainstream data management systems (e.g. Provantis, WATSON LIMS, etc.) are used to comprehensively and efficiently manage nonclinical research data.

4. One-stop services

TriApex can provide one-stop services including nonclinical efficacy, pharmacokinetics, and toxicology studies, regulatory strategy and IND submissions. We have supported IND applications of over 100 programs, including new chemical entities (including siRNA and its delivery systems), biologics (including antibodies, ADC, peptide drugs), cell therapies, gene therapies and traditional Chinese medicines.

Service Capacities


Single dose toxicity study

Repeat dose toxicity study

Genotoxicity study 

Carcinogenicity study

Reproduction toxicity study (fertility and early embryonic developmental study (FEED), embryo-fetal development study (EFD), pre- and postnatal development study (PPND))

Juvenile animal study

Local tolerance study

Safety pharmacology study 

Dose range finding study

Route of Administration


Subcutaneous injection

Intradermal injection

Intraperitoneal Injections

Intramuscular injection

Intravenous injection 

Intra-articular injection

Intraventricular injection

Percutaneous administration

Intranasal administration

Supporting Services

Formulation concentration analysis

Drug concentration determination in biological samples





Histopathology slides preparation and interpretation



Submission dossier preparation